SCHEMBL17245265

SCHEMBL17245265

CC(C)[C@@H](OC(C)(C)C)C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP3 P08254 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43
TP53 P04637 1/20 0.35
SLC7A5 Q01650 1/20 0.35
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
PTGS1 P23219 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31
PPARG P37231 2/20 0.30
PPARA Q07869 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10417536 1.00 MMP1 (0.43) MMP1MMP2MMP3MMP9MMP13
SCHEMBL17245264 1.00 MMP1 (0.43) MMP1MMP2MMP3MMP9MMP13
SCHEMBL1195466 0.87 SLC1A3 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL1196065 0.87 SLC1A3 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL6675517 0.87 SLC1A3 (0.39) MMP1MMP2MMP3MMP9MMP13
SCHEMBL24067986 0.76 ALDH1A1 (0.38) SLC1A3SLC1A2SLC1A1ALDH1A1
SCHEMBL12057009 0.76 SMN1; SMN2 (0.43) CA1CA2CA7
SCHEMBL10591979 0.75 SLC1A3 (0.45) MMP1MMP2MMP3MMP9MMP13
SCHEMBL9353746 0.75 TSHR (0.37) MMP1MMP2MMP3MMP9MMP13
SCHEMBL10434366 0.74 MAPK1 (0.34) MMP1MMP2MMP3MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150320753-A1 PURINE DERIVATIVE COMPOUNDS FOR MEDICAL USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-11-12 US disclosed
US-20150320753-A1 PURINE DERIVATIVE COMPOUNDS FOR MEDICAL USE NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320753-A1 PURINE DERIVATIVE COMPOUNDS FOR MEDICAL USE MSR1, TPMT, M6PR MMP1 2676/4885MMP2 2735/4885MMP3 2855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.